Posts Tagged ‘adoption of innovation’

We are most accustomed to technology bringing economic disruption. Three decades ago, it was the internet. Then smartphones and social media. Now, we obsess about the effects of artificial intelligence. But a strong case is building that obesity medicine is becoming an economic disruptor on a scale that is equal or greater than any of […]

Novo Nordisk went shopping this week and brought home a super-early-phase triple-G agonist for the low low price of $200 million in cash up front. On top of that, Novo will pay another $1.8 billion plus royalties if all goes well. That’s a tidy sum to pay for rights to a drug – UBT251 – […]

“This is a dream come true.” In her opening presentation yesterday to a diverse group of experts in cardiology, endocrinology, and healthcare, the renowned Donna Ryan was marveling at the broad interest surfacing in serious obesity care – reaching far beyond the limited bubble where it stayed for decades. The American College of Cardiology assembled […]

No two ways about it. This has been a big year of milestones in obesity and health. We and many others are still processing what we have witnessed in these past 12 months. But one way to gain perspective is to look at 2023 stats for the posts on ConscienHealth that you, a wise group […]

We are clearly on a path toward better obesity medicines, but reflecting on decades of work on this, clearly, the path is twisted. Describing this path, Gina Kolata writes: “Every so often a drug comes along that has the potential to change the world. Medical specialists say the latest to offer that possibility are the […]